Abstract
Infants born at extreme prematurity are at a high risk of developmental disability. A major risk factor for disability is having a low level of thyroid hormone, described as hypothyroxinemia, which is recognized to be a frequent phenomenon in these infants. At present, there is uncertainty among clinicians regarding the most appropriate method of managing hypothyroxinemia of prematurity. The literature suggests that some, but not all, forms of thyroid supplementation may reduce the incidence of disability in infants born at extreme prematurity. There is a pressing need to confirm the benefit of treatment and to establish the optimal way to treat transient hypothyroxinemia in these infants.
| Original language | English |
|---|---|
| Pages (from-to) | 453-462 |
| Number of pages | 10 |
| Journal | Expert Review of Endocrinology and Metabolism |
| Volume | 3 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 31 Jul 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Hypothyroxinemia
- Prematurity
- Thyroid hormonies
- Thyroxine T4
Fingerprint
Dive into the research topics of 'Hypothyroxinemia of prematurity: Cause, diagnosis and management'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver